share_log

翰宇药业(300199.SZ):替尔泊肽原料药获得美国DMF备案号

Hybio Pharmaceutical (300199.SZ): Tilapornide active pharmaceutical ingredient obtains US DMF registration number.

Gelonghui Finance ·  Jun 27 07:44

On June 27th, Gelonhui reported that Hybio Pharmaceutical (300199.SZ) received confirmation from the US Food and Drug Administration (FDA) on June 27th, 2024 that the submitted Thiopeptide Drugmaster file (DMF) had been received.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment